. Early embryonic development of Drosophila melanogaster is also unusual, yet genetic screens for mutations that disrupt it yielded the discovery of the Hedgehog and WNT pathways 3 . Few physicians or scientists would dispute the impor tance of these discoveries in simple organisms to human cancer. Nevertheless, it is not always obvious whether or how a particular experimental model will be relevant to cancer biology. Sometimes, relevance may become obvious only after years or decades, and all models have limitations. The direct study of human patient samples is also fraught with limitations and caveats, such as the inability to observe the process of metastasis as it unfolds, genetic heterogeneity of the patient population and constraints on sample sizes 4 . Nevertheless, DNA sequencing of thousands of human patient tumours has led to the identification of 54 oncogenes and 71 tumour suppressor genes that are repeatedly mutated in can cer 5 . The products of these genes fall into a handful of Lamellipodium A quasi-two-dimensional structure localized at the leading edge of motile cells that contains a highly dynamic actin network.
Lamellum
A structure containing stable actin filaments and mature adhesion sites localized just behind the lamellipodium.
Basement membrane
A thin, fibrous membrane that separates epithelium, mesothelium or endothelium from the underlying stroma.
key molecular pathways that confer a selective growth advantage to both primary tumours and their metastatic colonies. Intriguingly, cancer cells coopt these pathways from those that drive normal cell fate, proliferation and survival during embryonic and tissue development. We suggest that just as cancer cells exploit normal pathways to gain a growth advantage, they also hijack normal cellular processes and the molecular mechanisms that govern tissue morphogenesis to spread through the body in the process of metastasis
. This idea leads to an important question. What are the cellular processes and molecular pathways that control normal morphogenesis in multicellular organisms?
In this Review, we focus specifically on cell migra tion and invasion, which are central to morphogenesis and to multiple aspects of tumour metastasis. We high light examples of directed cell migration and invasion found in the normal development of nonmammalian organisms, the mechanistic insights gained from their study and their implications for understanding metas tasis. Increasingly, nonmammalian models such as flies and fish are also used to model the abnormal spread of tumour cells throughout the body and to screen for drugs that block such behaviour. The advantages of model organisms include low cost, the ability to carry out largescale genetic and pharmacological screens as well as biochemical analyses, and amenability to live, highresolution fluorescence microscopy of cells inter acting within native environments. These advantages have led to mechanistic insights into cell migration, invasion and metastasis that can be, and in some cases have been, tested for their importance to cancer inva sion and metastasis in mammalian models and even clinical studies.
Origin and diversity of cell migration Sensing and initiating directional movement in response to external cues is a fundamental property of biological systems -from individual cells to entire organisms. The ability to move towards food and other favourable envi ronments and away from starvation and generally hostile conditions is essential for organismal survival. The first organisms to evolve these behaviours were unicellular. During the evolution of multicellular organisms, this primitive capacity of cells to move directionally has been adapted for essential processes including embryogene sis, adult tissue homeostasis and immune responses [6] [7] [8] . Thus, the molecular mechanisms of cell motility are fundamentally intertwined with cell survival, a connec tion that is likely relevant to metastasis. However, cell migration is not one single phenomenon. In disparate physiological contexts, distinct cell types exhibit a vari ety of morphologies, cell-cell interactions and types of movement. Indeed, cells can move in amoeboid, mesen chymal or epithelial modes, as individuals or in clusters, strands, streams, sheets or fluidlike masses and can even switch dynamically between different modes in response to changing environments 9 . This diversity in migratory dynamics is accomplished by differential regulation of forces in space and time 9 . Key forces that are combined and tuned to different magnitudes and subcellular localizations to produce diverse cell migration behaviours include cell-substrate adhesion, cell-cell adhesion, cell cortex rigidity (which includes the plasma membrane and the underlying cortical cytoskeleton), actin polymerizationmediated protrusion and actomyosin contractility 10, 11 . In cells that strongly adhere to surfaces coated with extracellular matrix (ECM) proteins via focal adhesion complexes and associated stress fibres, transient protrusions and retractions of the leading edge are driven by polymer izing and depolymerizing actin within the lamellipodium. Further back, in the lamellum, integrinmediated adhe sions couple to contractile filamentous (F)actin stress fibres, engaging the 'clutch' of the cell. This engagement enables productive forward protrusion of the cell as new actin subunits are added to the fronts of anchored fil ament bundles. Young focal adhesions and stress fibres mature and become stronger, increasing forward protru sion 12 , whereas adhesions at the back loosen, resulting in anisotropic forces and forward movement. This type of behaviour, referred to as mesenchymal migration, is char acteristic of fibroblasts migrating on rigid surfaces such as coverslips coated with ECM proteins and likely best models migration on a basement membrane in vivo 9, 13 . By contrast, amoeboid migration refers to the movement of round or ellipsoid cells that do not strongly adhere to
Box 1 | The elusive metastatic programme
Many mutations that cause tumour growth and proliferation have been identified; however, metastasis genes have been more elusive 225 . While some metastasis genes have emerged [226] [227] [228] [229] , our mechanistic understanding remains incomplete 225, [230] [231] [232] . Why then has the metastatic programme escaped detection by the approaches that were successful in identifying tumour suppressors and oncogenes?
One answer might be that metastasis genes overlap substantially with those that drive growth and survival, making it impossible to tease out a separate programme. In fact, the signalling cascades that promote cancer growth and cell migration overlap extensively, perhaps because it is adaptive to migrate towards survival factors; this coupling can also eliminate errant cells. However, there is a key difference between the regulation of signalling pathways in chemotaxis compared with the regulation of pathways of growth, survival and proliferation. Chemotaxis requires spatially and temporally dynamic signalling, which is impaired by constitutive activation. For example, constitutively active RAS or PI3K signalling, which are frequently observed in cancer, should immobilize cells. Indeed, PTEN-mutant Dictyostelium discoideum are mostly paralysed 233 , as are Drosophila melanogaster border cells expressing Ras
G12V
(REF. 234 ). So how do cancer cells with activating mutations in these pathways spread? Perhaps motile immune cells, fibroblasts or cells lacking the mutation within the heterogeneous tumour serve as leader cells and guide or carry otherwise immobilized tumour cells 97, 219, 235, 236 . Alternatively, different cells may employ distinct pathways for chemotaxis, so a given cell type may tolerate constitutively activating mutations in the PI3K pathway, for example, but not in RAS. In fact, Pten-mutant border cells are able to migrate normally (D.J.M., unpublished observation), as are some Ras
-expressing tumour cells 237 . Such a mechanism might help explain why PTEN or RAS G12V mutations are common in only particular types of cancer. A third possibility is that tumour cells adapt to higher than normal levels of signalling, as D. discoideum cells do while migrating up a chemoattractant gradient.
High-throughput sequencing has focused attention on mutations as the drivers of phenotypic diversity in tumours, whereas during embryonic development, the entire organism builds itself in the absence of meaningful mutations. Instead, changes in gene expression drive many varieties of cell movement, including epithelial to mesenchymal transition (EMT), mesenchymal to epithelial transition (MET) and colonization of new sites. Another possibility, then, is that epigenetic changes, rather than mutations, primarily drive metastasis. the ECM 14 . Amoeboid migration is either driven by high actomyosin activity that leads to rapid actinrich front protrusions and back retractions or by actindevoid pro trusions known as blebs, which are driven by hydrostatic pressure and cytoplasmic flow 15 . In both cases, the rapid kinetics of protrusions and retractions, coupled with the weak and highly dynamic cell-substrate adhesions, result in fast and adaptable migration 13, 16 . In contrast to singlecell mesenchymal or amoeboid migration, epithe lial migration is characterized by migration of groups of cells that are interconnected by cell-cell adhesions and move as clusters, sheets, strands or fluidlike masses 17 . Additionally, the phenotype of migratory cells depends on the biochemical composition, stiffness and overall topography of the substrate. Conceptually, 1D, 2D or 3D environments can be distinguished 18 . An example of 1D migration is migration of cells along a single collagen fibre 19 . Cell migration on the endothe lial lining of vessels or along a basement membrane surface is 2D migration. Finally, cells surrounded by matrix or other cells on all sides move through a 3D environment 20, 21 .
While an early idea was that cells transition from one stable state, such as epithelial, mesenchymal or amoeboid, to another, we now appreciate that tumour cells are heterogeneous, plastic and adaptive. This is particularly important for understanding tumour cell migration, which can combine features of mesenchymal, epithelial and amoeboid modes to adapt to changing environments 22, 23 .
Migration and metastasis
Tumour metastasis is a complex phenomenon that has been widely reviewed [24] [25] [26] . Key features of metastasis, specifically with respect to epithelialderived carcino mas, include loss of epithelial polarity and breakdown of tissue architecture, breach of the basement mem brane, intravasation of tumour cells into blood and/or lymphatic vessels, escape of tumour cells from vessels (extravasation), migration of tumour cells into a new tissue and expansion of the metastatic colony 27 (FIG. 1) .
A major challenge in understanding metastatic tumour spread in patients is that the process cannot be observed or manipulated directly. Although histological Figure 1 | Simple model organisms can be used to investigate aspects of tumour invasion and metastasis. Metastasis is a multistep process during which tumour cells breach tissue borders (1); migrate in sheets, strands, streams and clusters (2); cross into and out of blood vessels (3) and form colonies at distant sites (4) . Immune cells and endothelial cells in the tumour microenvironment also migrate, either increasing or inhibiting tumour growth and spread. Simple organisms provide models for individual steps or features of this complex process and have been successfully used to contribute key concepts and mechanistic insights to the field of cancer research. studies of human tumour samples have provided the clinically useful stage and grade classification system 28, 29 , such approaches cannot reveal cellular or molecular dynamics of the metastatic process. In this regard, model organisms have much to offer. A key point is that simple model organisms need not recapitulate the entire meta static programme. Rather, the goal is to dissect it into individual steps that can be studied in depth (FIG. 1) . Here, we summarize some of the betterstudied experimental models of both normal and abnormal cell behaviours that mimic features of tumour metastasis and highlight key insights relevant for understanding human cancer.
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Danio rerio (Zebrafish)
Drosophila melanogaster
Non-mammalian model organisms Dictyostelium discoideum and chemotaxis. The mech anisms by which tumour cells travel to metastatic sites are complex, involving the motility of tumour cells themselves as well as the hijacking of motile host cells
. While the genetic basis of metastasis remains unclear
, signalling via chemokines is known to stimulate tumour cell migration, invasion into the local environment, homing of tumour cells to lymphatic vessels and metastatic sites, and infiltration of immune cells into tumours [30] [31] [32] [33] . The social amoeba Dictyostelium discoideum presents a simple model to study directed cell migration and chemokine signalling. The evolutionary conservation of chemokine signal ling pathways, accessible genetics and amenability to live imaging make D. discoideum an important model to examine basic molecular mechanisms that govern chemokinemediated chemotaxis 34, 35 . During nutrient deprivation, D. discoideum cells enter a developmental programme leading to sporulation. During this process, cells chemotax towards secreted cAMP, leading to the formation of aggregates that differ entiate into spore and stalk cells to form fruiting bodies 36 . Chemotactic migration is initiated when cAMP binds to the G proteincoupled receptor (GPCR) cAMP receptor 1 (cAR1). This leads to the dissociation of the G protein into Gα and Gβγ subunits, which then activate a vari ety of signalling cascades that converge to polarize the cell -a prerequisite for migration 37 . Cell polarization is accompanied by the redistribution of cytoskeletal components, with enrichment of dynamic Factin and numerous actinbinding proteins at the front, leading edge and myosin II assembly on the sides and at the back, trailing edge (FIGS 1,2). These highly orchestrated events result in a type of amoeboid migration that allows D. discoideum to navigate complex environments at speeds that can exceed 20 μm/min (REF. 34 ). Similarly, chemokine mediated and growth factormediated chemotaxis has been observed in tumours. For example, the chemo kine CXCchemokine ligand 12 (CXCL12; also known as SDF1), which is involved in the chemoattraction of bone marrowderived cells, can attract a variety of tumour cells, including those originating from breast, ovarian and colorectal tumours and melanoma 38 . In addition, immune cells, which chemotax to sites of inflammation and injury 39 , may be subverted by tumours to infiltrate tumour tissue and support tumour growth using similar chemotactic mechanisms [40] [41] [42] . A central question in the field of chemotaxis has been how chemotactic signals initiate and maintain cell polarity. Uniform stimulation of D. discoideum cells with chemoattractants leads to transient increases in calcium influx, inositol triphosphate (IP 3 ), cAMP and cGMP, as well as myosin II phosphorylation and actin polymeriza tion. By contrast, when D. discoideum cells are exposed to gradients of chemoattractants, these responses are spatially restricted and persistent. This occurs because chemoattractant receptor activation elicits both stimu latory and inhibitory signals that allow cells to adapt to external signals and maintain chemotactic sensitivity to external gradients where the concentration of chemo attractant is increasing 43, 44 . Work in D. discoideum pro vided the first evidence as to how this occurs. Use of green fluorescent protein (GFP) revealed that, whereas both cAR1 and its associated G protein remain uni formly distributed in chemotaxing cells, proteins har bouring pleckstrin homology (PH) domains that bind to phosphatidylinositol 3,4,5trisphosphate (PIP 3 ) spe cifically redistribute to the leading edge of chemotaxing cells [45] [46] [47] . This molecular underpinning of directed amoe boid migration was also observed in neutrophils 48 and in fibroblasts in response to gradients of plateletderived growth factor (PDGF) 49 . However, the role of localized PIP 3 signals in mesenchymal and epithelial migration remains unclear 50 .
The asymmetrical distribution of PIP 3 results from the spatial activation of PI3K at the front and PTEN at the sides and rear of cells 51, 52 . These localized PIP 3 sig nals therefore provide spatial orientation for PH domain containing proteins that act as adaptors for specific downstream cascades, which, in the case of chemotaxis, spatially nucleate actin assembly 53, 54 (FIG. 2) . In human
Box 2 | Cell migration in metastasis
The dominant view of the role of cell migration in metastasis has historically focused on the motility of tumour cells 238, 239 (see also BOX 3) . The preference of specific cancers for particular metastatic sites has been attributed to two mechanisms. For example, when colon cancers metastasize to the liver 240 , cells appear to settle at the first opportunity, carried via the blood or lymphatics until they encounter capillary beds, where blood flow slows enough for them to attach to the vessel wall and migrate out 241 . Alternatively, tumour cells might disperse throughout the body, where metastases succeed only in permissive environments (known as the seed and soil hypothesis). This appears to be the case for the metastasis of breast cancer to bone 242 . In both models, tumour cells are passively distributed throughout the body, and the role of tumour cell motility is to enable them to reach the vasculature, exit from vessels and invade distant tissues. To this end, cells might specifically follow gradients of chemokines such as CXC-chemokine ligand 12 (CXCL12) to exit vessels and migrate towards permissive metastatic niches 243, 244 . Alternatively, though, cancer cell clusters may settle passively as emboli, in which case motility of tumour cells themselves may not be essential for extravasation.
The motility of host cells is emerging as important for metastases. For example, as tumours grow and become hypoxic, they secrete angiogenic factors that cause blood vessels to migrate into the tumour, supplying it with oxygen and nutrients and bringing tumour cells close to vessels. Highly motile immune cells and cancer-associated fibroblasts likely also promote invasion and metastatic spread 216, 235, 245, 246 . However, cell motility does not only promote metastasis. T cell migration into tumours improves antitumour immune responses 247, 248 . In this case, therapeutic approaches that increase T cell migration into tumours may be helpful. Therefore, an effective therapeutic approach to preventing or treating metastasis on the basis of cell motility will likely require precise targeting of specific cell types rather than globally inhibiting migration. cancers, mutations in the PI3K-PTEN-mTOR com plex 1 (mTORC1) cascade are prevalent 55, 56 , potentially dysregulating the PIP 3 signals necessary for migration. In support of this, wortmannininduced depletion of PIP 3 is associated with an antimigratory response to lysophos phatidic acid (LPA) in mouse B16 melanoma cells 57 , and PI3K-AKT signalling can increase invasion by upregulat ing matrix metalloproteinase 9 (MMP9) 58, 59 . Additionally, PI3K is a key regulator of immune cell migration 60 as well as cellular processes such as cell growth, survival and differentiation 61, 62 . Thus, inhibitors of this pathway, which have been extensively studied to treat cancer 62 , likely exert pleiotropic effects on host cancerassociated cells, such as immune cells and fibroblasts, in addition to affecting the tumour cells directly.
Genetic screens are another powerful tool used to identify pathways controlling directed cell migration in D. discoideum. In this way, three independent pathways parallel to the PI3K-PTEN signalling cascade were identi fied in genetic screens for migration defective mutants: guanylyl cyclase (GC), phospholipase A2 (PLA2) and mTORC2 signalling 43, 63 . However, only a few inhibitory mechanisms of the chemotactic response have been identified, including specific inhibitory Gα subunits (for example, Gα9) and phosphorylation of the cAMP recep tor 64 . These inhibitory pathways confer adaptability of the chemokine signalling pathway, an essential feature of the chemotactic response that enables cells to detect increases in ligand concentrations over a large range of concentrations. Therefore, mutations in these pathways would also lead to defects in migration and metastasis.
The information gathered from D. discoideum has provided a blueprint to decipher chemotactic signalling in both leukocytes and cancer cells during inflammation, invasion and metastasis. Indeed, it has been proposed that in their most invasive form, metastatic cancer cells revert to the primitive mode of amoeboid migration that is shared by haematopoietic and D. discoideum cells 65, 66 . Furthermore, GC, PLA2 and mTORC2 signalling have all been implicated in the regulation of migration of a variety of human cancer cells [67] [68] [69] . For example, PLA2 and its lipid mediators stimulate RHOassociated protein kinase (ROCK) signalling 69, 70 , a key regulatory pathway of amoeboid migration 66 . Identifying the basic mechan isms that regulate chemotactic signalling may reveal how to increase the motility and invasion of tumour reactive T cells into tumours. This is an important frontier in expanding the current success of immunotherapeutic agents, as a key limitation to the effectiveness of these treatments is the inability of T cells to infiltrate tumours in a large fraction of patients 71 .
Caenorhabditis elegans and anchor cell invasion. Tumours that form within epithelia have little potential to spread when they remain confined by the basement membrane. Basement membranes also surround blood vessels and thus present a barrier to intravasation and extravasation. Therefore, crossing basement membranes is a key step in metastasis 72 . An elegant example of local basement membrane invasion is found in the nematode worm C. elegans 73 . During larval development, a single cell -the anchor Nature Reviews | Cancer cell -breaches two underlying basement membranes as part of normal morphogenesis of the vulva (FIGS 1,3 ).
The power of this model derives from its simplicity, the reproducibility of this stereotyped event, the clarity of the live imaging and the ease of genetic screening 74 . Specification of the anchor cell fate is the first known step in activating this physiological invasion pro gramme. Cell cycle arrest in G1 follows and is essential for further progress 75 . Chromatin modifications ensue, followed by upregulation of a set of transcription fac tors, including FOS1A, which is the C. elegans ortho logue of protooncogene FOS 76 , a protein strongly associated with cancer cell invasion 77 . In vertebrates, FOS dimerizes with protooncogene JUN to form the transcription factor activator protein 1 (AP1), which stimulates expression of MMPs. In C. elegans, down stream transcriptional targets of FOS1A include genes that encode cell-matrix adhesion molecules such as hemicentin and proteins that weaken or degrade basement membranes such as zinc metalloprotease 1 (ZMP1), a membranetype MMP 78 . An asyetunidentified cue from the underlying vulval cells activates the RHOfamily GTPase CDC42 within the anchor cell, causing the formation of a spe cial invasive domain within the plasma membrane that is enriched in specific lipids, cell-matrix adhe sion proteins, netrin-deleted in colorectal carcinoma (DCC) signalling, Factin regulators such as RAC, the enabled/vasodilatorstimulated phosphoprotein (ENA/VASP) family of proteins, cofilin and matrix remodelling factors, including MMPs 79 (FIG. 3) . Within this invasive domain, hundreds of dynamic protru sions called invado podia form. Eventually, one of them drills through the basement membrane, leading to the recruitment of more Factin regulators and the forma tion of a large invasive protrusion, which feeds back to Nature Reviews | Cancer shut down further production of dynamic invadopodia. This large protrusion then pushes the remaining base ment membrane aside, allowing the anchor cell to reach the underlying vulva cells to form the vulva 80 . Similarly, tumour cells extend actinbased invadopodia into the ECM and secrete MMPs 78, [81] [82] [83] . Virtually all the molecular components of this system, including FOS, RHO GTPases, MMPs and laminin (a major component of basement membranes), are conserved in mammals (including humans), and in many cases, they are clearly associated with invado podia formation during tumour cell invasion 81, 84, 85 . Therefore, the exquisite precision in the mechanistic analysis of this system has yielded several striking observations that are likely to be relevant to cancer cell invasion across basement membranes. One exam ple is the observation that an initially tiny hole in the basement membrane is enlarged by the formation of a massive protrusion that pushes the remaining base ment membrane aside 80 . This shows that the basement membrane can be removed, at least in part, through such physical means. In support of the general idea that cells can facilitate breaching of the basement membrane through mechanical (nonenzymatic) means in mammals too, a recent paper has shown that cancerassociated fibroblasts (CAFs) can also perform such a function 86 . This alternative mechanism to gener ating tracks by matrix degradation may be one of many reasons why MMP inhibitors have not been clinically successful in treating tumours 87, 88 . Thus, illuminating the mechanisms of anchor cell invasion may lead to the identification of drug targets that might be effective in combination with MMP inhibitors.
Another intriguing observation is that cell cycle arrest in G1 is a prerequisite for anchor cell invasion 75 . If tumour cells similarly cannot divide and migrate at the same time, in a phenomenon called the 'go or grow' hypothesis 89, 90 , then they must either temporarily exit the cell cycle in order to invade, which is certainly pos sible given the timescale over which metastasis occurs relative to the cell cycle, or invade as a cooperative group of cells in which some cells continue to prolifer ate while others exit the cell cycle for invasion and/or migration, as has been observed in studies of tumour invasive fronts 91 . Indeed, a dichotomy between pro liferation and migration has been observed in some neurological tumours such as astrocytomas 89, 90, 92 , and emerging evidence suggests that the 'metastatic unit' is commonly formed of polyclonal groups of cells rather than single cells 93 . Within these polyclonal groups, immobile tumour cells might be guided by highly motile tumour cells, immune cells or fibroblasts (known as the 'piggyback theory') through physical or para crine interactions [94] [95] [96] . In at least one example in H1299 nonsmallcell lung cancer (NSCLC) cells growing in 3D spheroids, the highly migratory and invasive 'leader' cells also actively promote the survival and prolifera tion of the less mobile 'followers' (REF. 97 ). A clear exam ple of cooperative migration of two mutually dependent cell types that occurs during normal development is described in the next section.
Drosophila melanogaster border cells. During normal morphogenesis as well as during tumour invasion, cells often move in groups 18, 98 , and at least in some animal models, cell clusters are more effective than individual cells at metastatic spread 91, 93, 99 . In colorectal cancer, and increasingly in additional cancers, detached cell clus ters, or 'buds' , are recognized as clinically important in biopsy samples and correlate with poor prognosis 100 . (FIG. 4) . Whereas mammals possess dozens of cytokines, five JAKs and seven STATs, the simpler fly genome encodes just three Upds, one Jak and one Stat (encoded by Stat92E). The discovery that Jak-Stat signalling stim ulates border cell migration was the first evidence for the role of this pathway in cell motility in vivo [103] [104] [105] . JAK-STAT signalling also promotes the motility of human cancer cells in vitro and in orthotopic xenografts 106, 107 and contributes to cell motility and metastasis of prostate 108 , pancreatic 109 , hepatocellular 110 , lung 111 and other carci nomas in a variety of experimental models (reviewed in REF. 112 ). Additionally, in another example of cooperative, collective cell migration, JAK-STAT signalling in CAFs promotes cancer cell invasion 113 . Within border cells, Stat is a key node in a tran scriptional network that activates the expression of hundreds of target genes 104, 105, 114 , many of which con tribute to migration. One transcriptional target is the receptor tyrosine kinase (RTK) PDGF and vascular endothelial growth factor (VEGF)receptor related (Pvr), which serves as a chemoattractant receptor 115 . Directionsensing by border cells is relatively complex, considering their straightforward trajectory. At least four chemoattractants secreted by the germline cells (15 nurse cells and one oocyte) activate two RTKs, Pvr and epidermal growth factor receptor (Egfr), expressed on border cell surfaces [115] [116] [117] [118] (FIG. 4) . Ectopic expression of the ligands for these RTKs is sufficient to redirect the cells, demonstrating their role in providing directional information 117 . RTK signalling activates both the MapkErk pathway and the Rho GTPase, Rac 101 . The role of Rac in promoting protrusion and migration in vivo was first demonstrated in the border cell system 119 . This protein is now known to be a critical node in the signalling and cytoskeletal networks that govern the motility of both normal and cancer cells 120, 121 . Activation of Rac in one cell of the migrating border cell cluster is sufficient to redirect the whole group, showing that differential Rac activity within the group is key to collective guidance 122 . Interestingly, Rac activation requires Pvr through the action of multiple guanine nucleotide exchange fac tors (GEFs) 115, 123 and Rab5dependent endocytosis 124 , consistent with work in HeLa cells 125 . Furthermore, Rab11dependent activation of moesin is essential for the lead cell to inhibit Rac activation in the followers 124 , providing specific insight into the mechanisms that maintain asymmetric signalling within a cell cluster.
While parallels between border cell migration and ovarian cancer motility have been noted 126 , which may relate to their common origin from somatic cells of the female reproductive organ, border cells may also serve more generally as a model for dissemination of collec tively moving, heterogeneous groups of migratory and nonmigratory cells. Determining the contribution of this type of motility to tumour metastasis is currently a very active line of investigation in lung 127 , breast 99 , pancreatic 128 , prostate 129 and other types of cancer 26 . Another key transcriptional target of Stat in the bor der cells is Ecadherin. Border cells elevate Ecadherin expression during migration 130 , highlighting an impor tant difference between collective cell migration and the epithelial to mesenchymal transition (EMT)
. Moreover, Ecadherin promotes border cell migration by three distinct mechanisms 131 , suggesting that molec ular programmes distinct from EMT exist to promote collective cell migration. First, high levels of Ecadherin at interfaces between polar cells and border cells bind the cluster together to ensure collective behaviour. Second, Ecadherin molecules on the border cells bind Ecadherin molecules on the nurse cells between which they migrate (in the absence of substantial ECM). At the leading edge, a positive feedback mechanism between Pvr and Egfr signalling, Racmediated actin polymeriza tion and Ecadherinmediated adhesion produces a large forwarddirected protrusion 131 (FIG. 4) . Here, Ecadherin fulfils a function similar to that of integrins at the leading edge of a cell migrating through ECM 21, 132 . Protrusions are more frequent, larger and persist longer in the lead ing cell(s) of the cluster. Third, Ecadherincontaining adherens junctions between individual border cells mechanically couple them so that the lead cell, pulling on the following cells, inhibits protrusions to the side and rear of the cluster and coordinates the motile forces of individual cells to promote collective forward move ment of the group. A simple physical model predicts that in 3D but not 2D environments, larger cell clusters should migrate faster 133 . In border cells, this correlation between size and speed holds true until clusters become so large that viscous drag from the surrounding tissue impedes their movement 133 . Interestingly, while many investigators have focused on the motility of individual tumour cells as the driving force for cancer metastasis, recent studies demonstrate that circulating tumour cell clusters are more efficient at seeding distant metastases and correlate with worse clinical outcomes than single circulating tumour cells 99, 134 . ECadherin expression varies greatly among tumour cell lines and among tumour types 135 . Although a large body of work suggests that reduced or atypical Ecadherin expression is a sign of increased malig nancy in tumours 136 , lossoffunction mutations in the gene encoding Ecadherin (CDH1) are prevalent only in gastric cancer (CbioPortal). Ecadherin may more commonly be dynamically regulated epigenetically in motile cells, enabling a greater variety of behaviours. For example, cells might undergo partial or transient down regulation of Ecadherin followed by its reexpression when they colonize distant sites 137 . Elevated Ecadherin is commonly found in circulating tumor cell clusters, established metastases and is characteristic of ovarian and inflammatory breast cancers 138 , both of which have poor prognoses. Like migrating border cells, collectively invading breast cancer cells are connected by homotypic Ecadherin junctions, which may similarly mechanically couple the cells 139 . Heterotypic Ecadherin-Ncadherin (also known as cadherin 2) junctions between tumour cells and CAFs also facilitate cooperative tumour cell movement and invasion 96 . As cadherins promote collective, cooperative, celloncell migration during border cell migration by multiple mechanisms, it may be that cadherins also pro mote metastasis by similar mechanisms during collec tive tumour cell dissemination. This raises the general notion that molecules with a negative effect on indi vidual cell migration might actively promote collective motility. Border cells also require apical-basal polarity to coord nate their movements 140 , raising the possibil ity that apical-basal polarity might be required for the spread of cancer by cell collectives. In addition, border cells require the Src42A tyrosine kinase for their migra tion 141 , raising the possibility that SRC kinases could have distinct roles in collective versus individual cell migration. Although it has not been studied extensively, there is evidence for SRC promoting collective cancer cell motility in 3D 142 . In addition to border cells, many diverse modes of cell motility are found throughout normal fly develop ment. Additional models of individual and collective cell motility include primordial germ cells (PGCs), which exhibit individual, amoeboid motility similar to immune cells [143] [144] [145] ; gastrulating mesoderm, which
Box 3 | The epithelial to mesenchymal transition controversy
The epithelial to mesenchymal transition (EMT) is a programme used repeatedly during embryonic development 249 . EMT refers to characteristic morphological changes that enable cells to leave an epithelium and move to a new location, where they can undergo the reverse process (mesenchymal to epithelial transition (MET)) to form new epithelial organs. A conserved molecular programme that involves expression of transcription factors including SNAIL1, TWIST, ZEB1 and ZEB2 (REF. 250 ) drives EMT and inhibits apical-basal polarity components and cell-cell adhesion proteins such as E-cadherin. EMT confers increased motility, the ability to survive when detached from the basement membrane extracellular matrix (ECM) and from epithelial neighbours, as well as radioresistance and chemoresistance, properties that should provide a selective advantage to tumour cells [250] [251] [252] . A vast body of literature correlates EMT-MET with metastasis 238, 250 . However, there are challenges to the simplest form of the EMT-MET hypothesis:
• Full EMT is rarely observed in histological specimens 253, 254 • Loss of E-cadherin does not always occur during tumour development 138 • EMT may be required not for the metastatic tumour spread of all cancer types but rather for acquisition of drug resistance 251, 252 • Single tumour cells are rarely found in clinical tumour specimens 254 , although single circulating tumour cells can be found 99 Indeed, circulating tumour cell clusters isolated from patient blood are 50 times more efficient at establishing metastases than single circulating tumour cells 99 , and artificially clustering breast cancer cells increase their metastatic efficiency by 100-fold 93 . Cell clustering could provide a number of advantages such as allowing mixtures of highly motile and highly proliferative cells to spread together and shielding the innermost cells from the immune system. Thus, two distinct conceptual frameworks have emerged. Collective cell motility programmes distinct from EMT may mediate metastasis. Alternatively, EMT proponents favour models in which cells adopt intermediate states that are most effective at metastasis. Resolution of this controversy is an exciting open area of research. Twist and Snail   146 ; haemocytes, the macrophages of the fly 147, 148 ; caudal visceral mesoderm, which undergoes EMT followed by collective, mesenchymal migration 149 ; dorsal closure, which represents an epithelial sheet movement 150 ; tracheal and salivary gland morpho genesis, which serve as general models for the devel opment of tubular organs such as blood vessels 151 ; and larval histoblasts, another example of epithelial sheet movement 152 . Thus, D. melanogaster can serve as a model for studies of many types of cell migration, with the technical advantages of sophisticated genetics and in vivo live imaging.
undergoes EMT mediated by the transcription factors
Drosophila melanogaster and tumour metastasis.
D. melanogaster can also serve as a more direct model for tumour metastasis. The first mutations that cause metastatic behaviour were characterized in D. melanogaster in the 1970s, before the tumour suppressor gene concept was firmly established in cancer biol ogy 153 . Genes such as lethal (2) giant larvae (l(2)gl), discs large (dlg) and scribbled (scrib) are named for the phenotypes they cause in developing D. melanogaster larvae. Cells homozygous for these mutations grow excessively and exhibit increased MMP expression, cell migration and the ability to spread throughout the organism when transplanted into a wildtype host 153 . These genes encode highly conserved proteins (LLGL, DLG and SCRIB in humans, respectively) that form a complex in epithelial cells that is essential for estab lishing and maintaining apical-basal polarity in ani mals from flies to humans 154 . The SCRIB-DLG-LLGL complex normally establishes the basolateral domain of an epithelial cell by excluding apical proteins such as partitioning defective 3 (PAR3), PAR6 and atypical protein kinase C (aPKC) from that region 155, 156 . Mutual antago nism between the PAR and SCRIB complexes ensures establishment and maintenance of two dis tinct membrane regions of differing compositions. This polarity promotes regular patterns of oriented cell division and the establishment of adherens and tight junctions and thus results in wellorganized epithelial architecture 157 . Loss of apical-basal polarity and aber rant expression or localization of human homologues of polarity proteins such as SCRIB, DLG and LLGL or PAR3 and PAR6 are considered hallmarks of carcino mas. As such, these proteins have been suggested to be tumour suppressors in humans, highlighting the rele vance of this model to human cancer 154, 158 . However, it is intriguing that the human homologues of scrib, dlg and l(2)gl are rarely deleted or mutated in cancer; rather, these genes are frequently amplified and/or over expressed (CbioPortal) [159] [160] [161] . These observations indi cate that the roles of SCRIB, DLG and LLGL proteins in tumour progression are poorly understood.
One possible explanation for the observed over expression of SCRIB, DLG and LLGL proteins in human cancers is that the overexpression causes mislocalization and a dominantnegative effect 162 . However, if this were true, then SCRIB, DLG and/or LLGL1 (the human gene encoding LLGL) should be mutated or deleted at least as often as they are amplified or overexpressed, which is not the case. Another possible explanation is that polarity proteins might suppress tumour initiation but promote tumour progression, similar to transforming growth factorβ (TGFβ) signalling, which is a tumour suppressor and metastasis promoter 163 . If this is true, these polarity proteins would presumably have to be suppressed by epigenetic mechanisms early in tumori genesis and then reexpressed during metastasis, as proposed for Ecadherin in EMT and mesenchymal to epithelial transition (MET) 137 . Maintenance of apicalbasal polarity is a key feature of collective epithelial motility 140 , so one possibility is that SCRIB, DLG and LLGL promote tumour progression by facilitating col lective cell migration, though it is unclear how over expression would enhance that behaviour. Further studies of the phenotypes caused by overexpression of SCRIB, DLG and LLGL are warranted.
The protein Scrib emerged independently in a sys tematic screen for metastatic cell behaviour in flies 157 . Clones of cells expressing active Ras (Ras G12V ) in lar val tissues overgrow but do not spread 157 . Therefore, a screen was conducted to identify recessive mutations that together with Ras G12V expression cause tumour cells to breach the basement membrane and spread throughout the fly; this identified scrib 164, 165 . Clones of cells lacking scrib are normally eliminated by apopto sis; however, scrib -/-cooperates with Ras G12V to cause massive overgrowth, EMT and MMP expression, lead ing to metastatic spread and colonization of distant organs 157 . Mutations in dlg and l(2)gl can substitute for scrib mutations in this context, thereby implicating loss of the basolateral complex as key to the metastatic pheno type 157 . Tissue injury or stress can also substitute for scrib -/-, suggesting that cells perceive loss of polarity as an injury or stress. Exactly how Ras G12V contributes is not clear because stimulating growth and proliferation, by overexpression of Myc or Akt, or inhibiting apopto sis allows scrib -/-cells to survive but is insufficient to substitute for Ras G12V in promoting spread throughout the organism 164 .
Remarkably, Ras
G12V and scrib mutations do not have to occur in the same cells to promote metastasis. Ras G12V expressing cells adjacent to scrib -/-cells over grow and metastasize 166 . The scrib -/-cells secrete Upd cytokines, activating the Jak-Stat signalling that is essen tial for tumour growth and metastasis. Importantly, the cytokines promote tumour growth even after the initial scrib -/-cells are outcompeted by the Ras G12V expressing cells. This key insight from the fly could explain why SCRIB, LLGL1 and DLG mutations are rarely detected in human cancer. Such cells may transiently promote tumour progression but ultimately become outcompeted.
Screens for additional mutations that enhance or sup press the Ras G12V scrib -/-phenotype have uncovered many genes contributing to metastasis in the fly 167 . A summary of some salient features of the pathways are illustrated in  FIG. 5 . Jun Nterminal kinase (Jnk; also known as Mapk) is a stressactivated kinase that at high levels triggers apoptosis 168 . However, in scrib -/-cells, Jnk promotes pro liferation and invasion 169 . Jnk signalling also stimulates cells to multiply in tissues that need repair (known as compensatory growth) and sustains tumour growth and invasion in flies [170] [171] [172] . Many of these findings are also true in human cancers and may well contribute to metasta sis 173 . For example, activation of JNK is necessary for cel lular transformation by oncogenic RAS, JNK stimulates cell proliferation by producing cytokines that activate the JAK-STAT pathway, and JNK promotes tumori genesis in hepatocellular carcinoma, gastric cancer, and tobaccoinduced lung cancer (reviewed in REF. 173 ).
A genetic screen for mutations that enhance or sup press fly eye defects caused by overexpression of the oncogenic form of the RET RTK gene, which is the gene mutated in the human cancer syndrome multiple endo crine neoplasia (MEN), a disease that includes medul lary thyroid carcinoma, identified mutations in the RAS, SRC, JNK and PI3K pathways 174 , illuminating critical downstream signalling pathways of oncogenic RET in vivo. In particular, the SRC pathway promotes cell invasion by altering Ecadherinmediated adhesion, inhibiting apoptosis and activating MMP expression (reviewed in REF. 175 ).
Remarkably, Dar et al. 176 tested a library of kinase inhibitors in a RETdriven D. melanogaster model in which a constitutively active form of the fly homologue of RET was expressed in the eye. They identified one kinase inhibitor with improved efficacy and reduced toxi city compared with vandetanib, which is the approved treatment for RETdependent thyroid cancer. The new drug also proved effective in mouse xenograft studies. For a detailed review of D. melanogaster as a model for identifying cancer drugs, see the publication by Sonoshita and Cagan 177 . Thus, despite the lack of blood or lymphatic vessels, D. melanogaster is a powerful model for identifying molecular pathways and cell-cell interactions that contribute to metastasis and systemic effects such as cachexia 178, 179 as well as promising drugs to treat cancer.
The zebrafish as a model for bleb-driven migration.
Cell motility driven by membrane blebbing is part of the repertoire of motility behaviours that cancer cells use to reach distant sites 180 . Cellular blebs are simple structures thought to represent a primordial mode of migration 181 . Remarkably, cells such as normal human fibroblasts, plated in confined spaces with limited cellsubstrate adhesion switch from a slowmoving mesen chymal phenotype to a fastmoving amoeboid migratory phenotype with the appearance of cellular blebs and high cellular contractility 182 . In addition to being a powerful model system to study immune cell migration in vivo 183 , the zebrafish (Danio rerio) has been central in our understanding of the mechanisms that regulate bleb formation through the study of PGC migration 184 . PGCs acquire the capa city to migrate by undergoing a series of differentiation steps beginning 3 hours after fertilization. PGC differ entiation depends on de novo transcription, the RNA binding protein dead end protein homologue 1 and the downregulation of Ecadherin 185 . Once polarized and motile, PGCs chemotax towards dynamic patches of Cxcl12a to reach their final destination, the primordial gonad. Cxcl12a binds to the GPCR CXCchemokine receptor 4b (Cxcr4b) and promotes the formation of cellular blebs that mediate PGC migration. Cxcr4b is uniformly distributed around the periphery of PGCs, but its activation is restricted to the side of the cells that is exposed to the highest concentration of Cxcl12a, leading to cell polarization and directional migration 186 . Interestingly, and in contrast to D. discoideum, neutro phils and fibroblasts [47] [48] [49] , PGCs exhibit a uniform dis tribution of PIP 3 on their surfaces, and depletion of PIP 3 from PGCs by expression of a dominantnegative form of the regulatory subunit of class 1A Pi3k does not alter their ability to migrate directionally 187 . Instead, chemokine receptor signalling triggers local calcium increases at the front of migrating PGCs. This results Nature Reviews | Cancer Metastasis models in Drosophila melanogaster have revealed that a variety of stresses activate the Jun N-terminal kinase (Jnk) pathway, which at high levels of signalling can lead to apoptosis. Alternatively, at lower levels or in the presence of oncogenic Ras, the Jnk pathway leads to autonomous and non-autonomous proliferation, expression of matrix metalloproteinases (MMPs), loss of E-cadherin and increased motility. Thus, the Jnk pathway is central to metastatic spread in the fly and likely also in human cancer 173 . BMP, bone morphogenetic protein; Dpp, decapentaplegic; Hid, Head involution defective; Jak, Janus kinase; Jnkk, Jnk kinase; Jnkkk, Jnkk kinase; pJun, phosphorylated Jun; ROS, reactive oxygen species; Rpr, Reaper; RTK, receptor tyrosine kinase; Stat, signal transducer and activator of transcription; TNF, tumour necrosis factor; Upd, unpaired; Wg, Wingless; Yap1, Yes-associated protein 1; Zfh2, zinc-finger homeodomain 2.
Mesendoderm
An embryonic tissue layer that differentiates into mesoderm and endoderm.
Directional persistence
A measure commonly defined as the ratio of displacement to trajectory length.
in a localized myosin activity that causes the blebs 188 . Furthermore, elevated pH at the front of migrating PGCs has recently been observed and proposed to be involved in their polarized migration 189 . While the advantages of blebbased migration are not fully under stood, the fast, energyefficient formation of blebs appears to be one mechanism by which individual cells can effectively explore complex 3D environments 15, 190, 191 . Intriguingly, zebrafish lateral mesendoderm progenitors alternate migratory phenotypes using blebs and actin rich protrusions to migrate in a manner characterized by 'runs' of high directional persistence and formation of directed actinrich protrusions, whereas less oriented 'tumbles' occur when blebbing is increased 192 . Similar switching between migratory phenotypes is also observed when tumour cells encounter chang ing environments. For example, experiments using micropatterns revealed that MDAMB231 breast cancer cells switch from a migratory phenotype dependent on integrin adhesion and actin polymerization in uncon fined spaces to a tubulindependent migratory pheno type in confined spaces 193, 194 . These findings suggest that the physical properties of the cellular microenvironment are one parameter that can induce switching between migratory phenotypes. However, it is not yet fully under stood which cellular or microenvironmental parameters, such as matrix composition, matrix density or cytokine levels, trigger such switches or what the consequences of switching migratory phenotypes are. The zebrafish model, which offers an imageable, 3D model of cell migration, may help answer these questions.
The zebrafish as a vertebrate model for tumour progression. In the past decade, zebrafish have emerged as a useful vertebrate model system to study the meta static cascade in vivo. Easy and costefficient to main tain relative to mammals, zebrafish can be genetically manipulated, have an innate and adaptive immune sys tem, vasculature, and have many of the same organs as humans [195] [196] [197] . Zebrafish embryos are particularly suitable for in vivo, highresolution, singlecell ima ging, as they are transparent and develop outside the mother [198] [199] [200] . In addition to these advantages, zebrafish do not have a functional adaptive immune system until 14 days after fertilization and thus lend themselves to xenograft models 201 . Recently, optically clear and immunocompro mised V(D)J recombinationactivating protein 2 (Rag2) mutant fish, which harbour a reduced number of T cells and B cells, became available for xenograft studies in embryos and adult fish [202] [203] [204] . Inoculation of immuno compromised zebrafish with patientderived breast or neuroendocrine tumour tissue resulted in meta static tumour spread that reflected or predicted the disease course in patients 205, 206 . Thus, zebrafish represent a lower cost model that may be used to predict metastatic tumour spread on the basis of patient material.
On a mechanistic level, the zebrafish model has been used to study intravasation and extravasation of tumour cells -critical steps during tumour spread that are still poorly understood, are difficult to observe in vivo and cannot be modelled in flies or worms. Injection of GFPlabelled human tumour cells into the abdominal cavity of embryonic zebrafish revealed that tumour cells secrete VEGF, which stimulates vascular remodel ling and the formation of openings (called portholes) at the sites of remodelling. The cells then extend protru sions into the portholes in a RHOCdependent manner, followed by tumour cell intravasation and dispersal 207 . Inprostate cancer cells, RHOC or ROCK1 and ROCK2 depletion by RNAi was also shown to reduce cancer cell adhesion to endothelial cells and transendothelial migration 208 . Furthermore, this vascular remodelling has been observed in extravasating tumour cells in mice using electron microscopy and has been shown to be increased by the presence of VEGF 209 . Similarly, using realtime intravital imaging, the Condeelis group has shown that VEGF signalling in macrophages causes the local loss of endothelial cell junctions and vascu lar permeability 210 , which could possibly also involve portholelike structures.
Injection of GFPlabelled human cancer cell lines into the common cardinal vein of fish embryos revealed that extravasation of tumour cells is also an active pro cess. Realtime intravital imaging in zebrafish revealed that at sites of extravasation, arrested tumour cells induce clustering of endothelial cells and alterations of cell-cell junctions 211 . Moreover, it was shown that while intravascular migration of tumour cells is dependent on β1 integrin adhesion to the blood vessel wall, the expression of TWIST, an EMTrelated transcription fac tor, increased intravascular migration and extravasation in a β1 integrinindependent manner 211 . The zebrafish model thus extends and confirms the anchor cell model in C. elegans that identified a role for β1 integrin in anchor cell invasion 212 . More recently, β1 integrin has been shown to be required for tumour cell extravasation in a 3D model of human microvasculature, specifically mimicking invasion past the endothelial basement membrane 213 , and CDC42 has been reported to pro mote transendothelial migration of prostate cancer cells through β1 integrin 214 . Thus, β1 integrin is implicated in transendothelial and transepithelial migration in three different model systems, implying that this integ rin has a conserved role in the migration of cells across basement membranes.
Interactions between tumour cells and other types of cells during tumour progression is another area that is highly relevant for our understanding of tumour disease, but difficult to observe. Of special interest are immune cells that have a complex role in tumour development 215 . For example, macrophages can support or limit tumour growth 216 . In mammals, interactions between tumour cells and macrophages through an EGF-macrophage colonystimulating factor 1 (CSF1) paracrine loop enable the formation of a tripartite arrangement between tumour cells, macrophages and endothelial cells (referred to as the tumour micro environment of metastasis (TMEM)) that is critical for intravasation [216] [217] [218] [219] [220] . Intravasation of tumour cells within the primary mouse mammary tumour occurs preferen tially at the TMEM and is dependent on VEGF signal ling from macrophages and subsequent loss of vascular junctions and transiently increased vascular permeabil ity 210 . Interestingly, while inhibition of Vegf signalling in zebrafish inhibits primary tumour vascularization, it has been shown to increase the formation of micro metastases at distal sites by increasing neutrophil migra tion, which deforms the collagen matrix and supports tumour cell invasion 221 . In zebrafish, human tumour associated macrophages (TAMs) such as activated M2 macrophages and TAMs isolated from breast, lung, colorectal and endometrial cancers, increase metastasis of murine T241 fibrosarcoma cells by interacting with tumour cells and facilitating intravasation 222 . Thus, the zebrafish emerges as a nonmammalian model system that lends itself to costefficient studies of aspects of tumourrelated disease. Furthermore, zebrafish can easily be exposed to carcinogens or drugs, making them a potential system for highthroughput screening studies and personalized treatments 196, 223 .
Perspectives
Despite decades of study, metastasis remains the major cause of mortality in patients with cancer. In addition to traditional mouse models, nonmammalian model organisms will continue to contribute key insights into the basic mechanisms of both normal and pathological cell migration as well as the development of therapies for cancer and metastasis. These models offer advantages that include highresolution live imaging, the ability to screen thousands of organisms relatively quickly and inexpensively, and genetic tractability. Studies of D. discoideum have uncovered the complex signalling networks that drive chemokinedirected cell motility, which is also a feature of tumour and immune cell migration. Work in C. elegans demonstrated that cells can push basement membranes aside in addition to enzymatically degrading them, offering a new mechanism to target for this key step in metastasis, assuming it proves to be conserved in human cancer. In D. melanogaster and zebrafish, diverse modes of collective and individual cell migration that occur during normal morphogenesis as well as in simple and relatively inexpensive models of tumour metastasis have been described. Border cells show that molecular mechanisms of cooperative, collective cell migration can differ in important ways from those of singlecell migration, which is exemplified by the positive role of Ecadherin in collective directionsensing of the border cells. D. melanogaster metastasis models have revealed signalling networks within tumour cells and between tumour cells and their neighbours in addition to systemic factors that promote the growth and spread of abnormal cells. D. melanogaster is also a valuable model for cancer drug discovery and optimization. Zebrafish offer the simplest and least expensive model for directly observing intravasation and extravasation.
While the experimental advantages of these models have elucidated critical concepts as well as molecular pathways and candidate treatments, many open ques tions remain. It is important to appreciate that cell migration contributes both positively and negatively to tumour metastasis. For example, stromal cells such as tumourassociated fibroblasts and macrophages can enable tumour cell invasion, intravasation, extravasa tion and colonization of new sites 217, 220, 224 , whereas T cell migration into a solid tumour is essential for the success of stateoftheart immune therapies 71 . Therefore, it will be crucial to reveal the molecular underpinnings of all types of motility and to identify differences between them that can be exploited therapeutically. As described in this Review, examples of different types of normal and abnormal cell migration abound in nonmammalian model organisms and are likely to yield key insights into how to promote beneficial antitumour T cell migration while inhibiting the motility of metastasispromoting cells. Understanding how tumour cells switch between different modes may also present opportunities for therapeutic intervention.
All models have limitations. For example, D. discoideum, D. melanogaster and C. elegans lack blood and lymphatic vessels, which are recognized barriers to metastasizing cancer cells in mammals. However, time and again, we are surprised by the degree of con servation of fundamental cellular properties and their underlying molecular mechanisms, and many important insights into the molecular mechanisms driving cancer have come from the study of normal cell and develop mental biology. Components of the WNT, Hedgehog, RTK, MAPK, Notch and apoptotic pathways, as well as telomerase and more, were elucidated from work on the normal biology of simple model organisms. Now, direct modelling of metastasis and testing of drugs in organ isms ranging from D. melanogaster to zebrafish and mice also appear extremely promising. Breakthroughs frequently occur when work in simple animals and mammalian models converge.
